A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : sFlt-1

Search Conditions:
Search Keyword : sFlt-1
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: sFlt-1
Appearance Frequency: 778 time(s)
Long forms: 29

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
soluble fms-like tyrosine kinase-1
(610 times)
Obstetrics
(193 times)
PlGF (308 times)
PE (145 times)
VEGF (113 times)
2001 Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.
soluble Flt-1
(49 times)
Medicine
(8 times)
VEGF (16 times)
PlGF (7 times)
sEng (7 times)
2000 Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen--a review.
soluble VEGF receptor-1
(49 times)
Vascular Diseases
(8 times)
VEGF (31 times)
PlGF (7 times)
Ang II (4 times)
2002 VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels.
soluble vascular endothelial growth factor receptor-1
(31 times)
Medicine
(4 times)
VEGF (12 times)
PlGF (8 times)
CABG (2 times)
2004 Suppression of lung metastasis of renal cell carcinoma by the intramuscular gene transfer of a soluble form of vascular endothelial growth factor receptor I.
soluble form of VEGF receptor 1
(9 times)
Pharmacology
(1 time)
VEGF (7 times)
PlGF (2 times)
BMI (1 time)
2002 Soluble FLT-1 expression suppresses carcinomatous ascites in nude mice bearing ovarian cancer.
soluble fms-like tyrosine-1
(3 times)
Physiology
(1 time)
Ang II (1 time)
AT1 (1 time)
CI (1 time)
2013 Control of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-alpha.
soluble form of Flt-1
(3 times)
Neoplasms
(2 times)
VEGF (2 times)
Flt (1 time)
2001 Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays.
soluble receptor, fms-like tyrosine kinase 1
(3 times)
Medicine
(1 time)
8-SPT (1 time)
BP (1 time)
COX (1 time)
2005 Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
cytokines fms-like tyrosine kinase-1
(1 time)
Vascular Diseases
(1 time)
CIMT (1 time)
CKD (1 time)
CVD (1 time)
2014 Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.
10  inhibitor-soluble Fms-like tyrosine kinase-1
(1 time)
Perinatal Care
(1 time)
IUGR (1 time)
PlGF (1 time)
SGA (1 time)
2013 Placental growth factor (PlGF): a key to optimizing fetal growth.
11  Sarcoma- (fms-) like tyrosine kinase-1
(1 time)
Pregnancy
(1 time)
ADMA (1 time)
PE (1 time)
PlGF (1 time)
2018 Clinical Presentation of Preeclampsia and the Diagnostic Value of Proteins and Their Methylation Products as Biomarkers in Pregnant Women with Preeclampsia and Their Newborns.
12  secreted form of Flt-1
(1 time)
Endocrine System Diseases
(1 time)
EVs (1 time)
PE (1 time)
VEGF (1 time)
2017 Micro- and Nano-vesicles from First Trimester Human Placentae Carry Flt-1 and Levels Are Increased in Severe Preeclampsia.
13  secretion of fms-like tyrosine kinase-1
(1 time)
Pharmacology
(1 time)
PE (1 time)
PlGF (1 time)
VEGF (1 time)
2018 Nutraceutical Targeting of Placental Synthesis of Soluble Fms-Like Tyrosine Kinase- 1 (sFlt-1) as Strategy for Preventing and Controlling Pre-eclampsia.
14  serum levels of soluble tyrosine kinase-1
(1 time)
Hypertension, Pregnancy-Induced
(1 time)
AUC (1 time)
IUGR (1 time)
PAPP-A (1 time)
2018 Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
15  showed high correlation: Pearson's correlation coefficients were 0.913
(1 time)
Chemistry, Clinical
(1 time)
PlGF (1 time)
SD (1 time)
2019 Elecsys and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable?
16  slopes ranging from 0.96 to 1.05
(1 time)
Biochemistry
(1 time)
AUROC (1 time)
CI (1 time)
PlGF (1 time)
2020 Verification of placental growth factor and soluble-fms-like tyrosine kinase 1 assay performance in late pregnancy and their diagnostic test accuracy in women with reduced fetal movement.
17  soluble binding protein fms-like tyrosine kinase-1
(1 time)
Biochemistry
(1 time)
AO (1 time)
HPAEC (1 time)
2009 A potential role for reactive oxygen species and the HIF-1alpha-VEGF pathway in hypoxia-induced pulmonary vascular leak.
18  soluble factors: soluble VEGFR1
(1 time)
Neoplasms
(1 time)
VEGF (1 time)
2013 Compartment model predicts VEGF secretion and investigates the effects of VEGF trap in tumor-bearing mice.
19  soluble FMS toll-like tyrosine kinase-1
(1 time)
Acquired Immunodeficiency Syndrome
(1 time)
HAART (1 time)
PlGF (1 time)
2013 High viral load and elevated angiogenic markers associated with increased risk of preeclampsia among women initiating highly active antiretroviral therapy in pregnancy in the Mma Bana study, Botswana.
20  soluble FMS tyrosine kinase-1
(1 time)
Gynecology
(1 time)
CON (1 time)
L-NAME (1 time)
LPS (1 time)
2019 [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
21  soluble fms-tyrosine-like kinase-1
(1 time)
Rheumatology
(1 time)
CVEs (1 time)
PlGF (1 time)
sEng (1 time)
2017 Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus?
22  soluble form of the Flt-1 vascular endothelial growth factor receptor
(1 time)
Neoplasms
(1 time)
neu mice (1 time)
2003 Cooperative effect between immunotherapy and antiangiogenic therapy leads to effective tumor rejection in tolerant Her-2/neu mice.
23  soluble form of vascular endothelial growth factor receptor type 1
(1 time)
Chemistry, Clinical
(1 time)
PE (1 time)
PlGF (1 time)
sEng (1 time)
2015 Is the imbalance between pro-angiogenic and anti-angiogenic factors associated with preeclampsia?
24  soluble fragment of VEGF receptor Flt-1
(1 time)
Pharmacology
(1 time)
PEG (1 time)
PEI (1 time)
VEGF (1 time)
2005 Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis.
25  soluble truncated form of Flt-1
(1 time)
Biochemistry
(1 time)
mFlt-1 (1 time)
VEGF (1 time)
2000 Identification of a vascular endothelial growth factor (VEGF) antagonist, sFlt-1, from a human hematopoietic cell line NALM-16.
26  soluble vascular endothelial growth factor receptor, fms-like tyrosine kinase-1
(1 time)
Gynecology
(1 time)
PlGF (1 time)
2007 Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke.
27  soluble VEGF receptor 1 protein
(1 time)
Biochemistry
(1 time)
VEGF (1 time)
2003 Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.
28  soluble VEGFR1 protein
(1 time)
Cardiology
(1 time)
VEGF (1 time)
VEGFRs (1 time)
2007 Expression and function of vascular endothelial growth factor receptors (Flt-1 and Flk-1) in vascular adventitial fibroblasts.
29  trophoblast-soluble Fms-like tyrosine kinase 1
(1 time)
Embryology
(1 time)
ELISAs (1 time)
HUVEC (1 time)
PlGF (1 time)
2014 Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.